Considerations in Treating Insomnia During Pregnancy: A Literature Review.
BACKGROUND
The prevalence of pregnancy-associated insomnia is high. Although insomnia may flow from normal physiologic features of pregnancy, it may also be an early warning sign of a relapse, or a trigger for a relapse, of a psychiatric illness. Those at risk for psychiatric illnesses may require medications as well as behavioral and psychotherapeutic interventions, to prevent relapse in the perinatal period. Unfortunately, few reviews of psychotropics used to treat pregnancy-related sleep disorders exist.


OBJECTIVE
We discuss issues related to sleep and sleep disorders in pregnancy in the context of co-morbid psychiatric illness, and review the literature on the commonly-used medications (e.g., benzodiazepines, sedative-hypnotics, antihistamines, trazodone, and melatonin) for insomnia during pregnancy.
['Chaudhry|Simriti K|SK|', 'Susser|Leah C|LC|']
D001569:Benzodiazepines D002492:Central Nervous System Depressants D005260:Female D006633:Histamine Antagonists D006801:Humans D006993:Hypnotics and Sedatives D008550:Melatonin D011247:Pregnancy D011248:Pregnancy Complications D011619:Psychotropic Drugs D017367:Serotonin Uptake Inhibitors D007319:Sleep Initiation and Maintenance Disorders D014196:Trazodone
insomnia pregnancy medication safety sleep medications women's mental health